TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 28 filers reported holding TALIS BIOMEDICAL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,373 | -2.0% | 27,860 | 0.0% | 0.00% | – |
| Q1 2023 | $13,652 | +9.9% | 27,860 | 0.0% | 0.00% | – |
| Q4 2022 | $12,417 | -34.6% | 27,860 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | -13.6% | 27,860 | 0.0% | 0.00% | – |
| Q2 2022 | $22,000 | -87.4% | 27,860 | -77.5% | 0.00% | – |
| Q1 2022 | $175,000 | -65.8% | 123,761 | -3.0% | 0.00% | – |
| Q4 2021 | $511,000 | -37.5% | 127,628 | -2.3% | 0.00% | – |
| Q3 2021 | $817,000 | -46.7% | 130,617 | -5.9% | 0.00% | – |
| Q2 2021 | $1,532,000 | -13.9% | 138,812 | +0.2% | 0.00% | – |
| Q1 2021 | $1,779,000 | – | 138,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|